Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 428950, 8 pages
http://dx.doi.org/10.1155/2012/428950
Research Article

Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System

1APEIRON Biologics AG, Campus-Vienna-Biocenter 5, 1030 Vienna, Austria
2Graz University of Technology, Rechenbauerstraße 12, 8010 Graz, Austria
3University of Graz, Universitätsplatz 3, 8010 Graz, Austria

Received 2 September 2011; Revised 27 October 2011; Accepted 27 October 2011

Academic Editor: Anderson J. Ferreira

Copyright © 2012 Marko Poglitsch et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Stegbauer and T. M. Coffman, “New insights into angiotensin receptor actions: from blood pressure to aging,” Current Opinion in Nephrology and Hypertension, vol. 20, no. 1, pp. 84–88, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. Y. C. Zhu, Y. Z. Zhu, N. Lu, M. J. Wang, Y. X. Wang, and T. Yao, “Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling,” Clinical and Experimental Pharmacology and Physiology, vol. 30, no. 12, pp. 911–918, 2003. View at Publisher · View at Google Scholar
  3. L. Zhou, R. Zhang, W. Yao et al., “Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression,” Tohoku Journal of Experimental Medicine, vol. 217, no. 2, pp. 123–131, 2009. View at Publisher · View at Google Scholar
  4. Z. J. Cheng, H. Vapaatalo, and E. Mervaala, “Angiotensin II and vascular inflammation,” Medical Science Monitor, vol. 11, no. 6, pp. RA194–RA205, 2005. View at Google Scholar
  5. W. R. Huckle and H. Shelton Earp, “Regulation of cell proliferation and growth by angiotensin II,” Progress in Growth Factor Research, vol. 5, no. 2, pp. 177–194, 1994. View at Google Scholar
  6. S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie, and A. J. Turner, “A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase,” Journal of Biological Chemistry, vol. 275, no. 43, pp. 33238–33243, 2000. View at Publisher · View at Google Scholar · View at PubMed
  7. C. M. Ferrario, M. C. Chappell, E. A. Tallant, K. B. Brosnihan, and D. I. Diz, “Counterregulatory actions of angiotensin-(1-7),” Hypertension, vol. 30, no. 3, pp. 535–541, 1997. View at Google Scholar · View at Scopus
  8. R. A. S. Santos, A. C. Simoes e Silva, C. Maric et al., “Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8258–8263, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. Zhong, R. Basu, D. Guo et al., “Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction,” Circulation, vol. 122, no. 7, pp. 717–728, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Donoghue, F. Hsieh, E. Baronas et al., “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9,” Circulation Research, vol. 87, no. 5, pp. E1–E9, 2000. View at Google Scholar · View at Scopus
  11. Y. Imai, K. Kuba, and J. M. Penninger, “The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice,” Experimental Physiology, vol. 93, no. 5, pp. 543–548, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. A. Crackower, R. Sarao, G. Y. Oudit et al., “Angiotensin-converting enzyme 2 is an essential regulator of heart function,” Nature, vol. 417, no. 6891, pp. 822–828, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. G. Y. Oudit, Y. Imai, K. Kuba, J. W. Scholey, and J. M. Penninger, “The role of ACE2 in pulmonary diseases—relevance for the nephrologist,” Nephrology Dialysis Transplantation, vol. 24, no. 5, pp. 1362–1365, 2009. View at Publisher · View at Google Scholar · View at PubMed
  14. B. Treml, N. Neu, A. Kleinsasser et al., “Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets,” Critical Care Medicine, vol. 38, no. 2, pp. 596–601, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. H. Österreicher, K. Taura, S. De Minicis et al., “Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice,” Hepatology, vol. 50, no. 3, pp. 929–938, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. F. Lovren, Y. Pan, A. Quan et al., “Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis,” American Journal of Physiology, vol. 295, no. 4, pp. H1377–H1384, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. C. Vickers, P. Hales, V. Kaushik et al., “Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase,” Journal of Biological Chemistry, vol. 277, no. 17, pp. 14838–14843, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. G. I. Rice, D. A. Thomas, P. J. Grant, A. J. Turner, and N. M. Hooper, “Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism,” Biochemical Journal, vol. 383, no. 1, pp. 45–51, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. T. Komatsu, Y. Suzuki, J. Imai et al., “Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2),” DNA Sequence, vol. 13, no. 4, pp. 217–220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Ferrario, J. Jessup, P. E. Gallagher et al., “Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors,” Kidney International, vol. 68, no. 5, pp. 2189–2196, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. N. Iyer, M. C. Chappell, D. B. Averill, D. I. Diz, and C. M. Ferrario, “Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan,” Hypertension, vol. 31, no. 2, pp. 699–705, 1998. View at Google Scholar · View at Scopus
  22. B. Mari, J. P. Breittmayer, S. Guerin et al., “High levels of functional endopeptidase 24.11 (CD10) activity on human thymocytes: preferential expression on immature subsets,” Immunology, vol. 82, no. 3, pp. 433–438, 1994. View at Google Scholar · View at Scopus
  23. R. Tran-Paterson, G. Boileau, V. Giguere, and M. Letarte, “Comparative levels of CALLA/neutral endopeptidase on normal granulocytes, leukemic cells, and transfected COS-1 cells,” Blood, vol. 76, no. 4, pp. 775–782, 1990. View at Google Scholar · View at Scopus
  24. Z. W. Lai, I. Hanchapola, D. L. Steer, and A. I. Smith, “Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints,” Biochemistry, vol. 50, no. 23, pp. 5182–5194, 2011. View at Publisher · View at Google Scholar · View at PubMed
  25. M. P. Ocaranza, S. Lavandero, J. E. Jalil et al., “Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro,” Journal of Hypertension, vol. 28, no. 5, pp. 1054–1064, 2010. View at Publisher · View at Google Scholar · View at Scopus